SCHEDULE 1 - PARENT ONLY FINANCIAL INFORMATION - Summary of Condensed Balance Sheet (Detail) - USD ($) $ / shares in Units, $ in Thousands |
Mar. 31, 2023 |
Dec. 31, 2022 |
Sep. 30, 2022 |
Jun. 30, 2022 |
Mar. 31, 2022 |
Dec. 31, 2021 |
Sep. 30, 2021 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|
Non-current assets | ||||||||||
Total assets | $ 676,529 | $ 688,736 | $ 758,973 | $ 770,255 | $ 781,153 | $ 760,337 | $ 762,295 | $ 702,986 | $ 701,456 | |
Long-term liabilities | ||||||||||
Warrant liability | 30 | 33 | 33 | 153 | 259 | 286 | 273 | 13,561 | 13,520 | |
Total liabilities | 511,834 | 508,064 | 513,250 | 511,059 | 511,295 | 492,815 | 482,733 | 430,944 | 423,945 | |
Stockholders’ equity | ||||||||||
Common stock, voting; par value $0.0001 per share; 315,000,000 shares authorized, 76,292,241 and 72,027,743 shares issued and outstanding at December 31, 2022 and December 31, 2021 | $ 8 | $ 8 | 8 | 8 | 8 | $ 7 | $ 7 | 3 | 3 | |
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 | $ 0.0001 | ||||||
Common stock, shares authorized (in shares) | 315,000,000 | 315,000,000 | 315,000,000 | |||||||
Common stock, shares issued (in shares) | 76,552,595 | 76,292,241 | 72,027,743 | |||||||
Common stock, shares outstanding (in shares) | 76,552,595 | 76,292,241 | 72,027,743 | 71,810,419 | ||||||
Additional paid-in capital | $ 437,677 | $ 435,292 | 432,566 | 429,547 | 427,046 | $ 413,315 | $ 412,985 | 121,321 | 128,538 | |
Accumulated other comprehensive loss | (6,262) | (6,390) | (8,174) | (5,959) | (3,586) | (3,463) | (3,295) | (2,040) | (2,458) | |
Accumulated deficit | (266,728) | (248,238) | (178,677) | (164,400) | (153,610) | (142,337) | (130,135) | (125,762) | (119,560) | |
Total stockholders’ equity | 164,695 | 180,672 | 245,723 | 259,196 | 269,858 | 267,522 | 279,562 | (6,478) | 6,523 | $ 16,496 |
Total liabilities and stockholders’ equity | $ 676,529 | 688,736 | $ 758,973 | $ 770,255 | $ 781,153 | 760,337 | $ 762,295 | $ 702,986 | $ 701,456 | |
Parent Company | ||||||||||
Non-current assets | ||||||||||
Investment in subsidiaries | 192,549 | 256,725 | ||||||||
Total non-current assets | 192,549 | 256,725 | ||||||||
Total assets | 192,549 | 256,725 | ||||||||
Long-term liabilities | ||||||||||
Warrant liability | 33 | 286 | ||||||||
Total liabilities | 33 | 286 | ||||||||
Stockholders’ equity | ||||||||||
Common stock, voting; par value $0.0001 per share; 315,000,000 shares authorized, 76,292,241 and 72,027,743 shares issued and outstanding at December 31, 2022 and December 31, 2021 | $ 8 | $ 7 | ||||||||
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 | ||||||||
Common stock, shares authorized (in shares) | 315,000,000 | 315,000,000 | ||||||||
Common stock, shares issued (in shares) | 76,292,241 | 72,027,743 | ||||||||
Common stock, shares outstanding (in shares) | 76,292,241 | 72,027,743 | ||||||||
Additional paid-in capital | $ 435,293 | $ 401,690 | ||||||||
Accumulated other comprehensive loss | (6,390) | (3,463) | ||||||||
Accumulated deficit | (236,394) | (141,795) | ||||||||
Total stockholders’ equity | 192,517 | 256,439 | ||||||||
Total liabilities and stockholders’ equity | $ 192,550 | $ 256,725 |
X | ||||||||||
- Definition Warrant Liability No definition available.
|
X | ||||||||||
- Definition Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of investment in equity method investee and investment in and advance to affiliate. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Details
|